Cargando…
Effectiveness, economical and safety aspects of growth hormone (GH) therapy in growth promoting doses in patients with isolated GH deficiency after the attainment of near-final height. Is there a need to modify the criteria of therapy withdrawal?
INTRODUCTION: Apart from growth promotion, growth hormone (GH) has important metabolic effects. Patients with severe GH deficiency (GHD) should be treated with GH throughout life. Current criteria for growth promoting therapy withdrawal in Poland differ from the latest recommendations. AIM OF THE ST...
Autores principales: | Smyczyńska, Joanna, Hilczer, Maciej, Lewinski, Andrzej, Smyczyńska, Urszula, Stawerska, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226357/ https://www.ncbi.nlm.nih.gov/pubmed/35114767 http://dx.doi.org/10.5114/pedm.2021.112694 |
Ejemplares similares
-
Thyroid function in children with growth hormone (GH) deficiency during the initial phase of GH replacement therapy - clinical implications
por: Smyczynska, Joanna, et al.
Publicado: (2010) -
Do IGF-I concentrations better reflect growth hormone (GH) action in children with short stature than the results of GH stimulating tests? Evidence from the simultaneous assessment of thyroid function
por: Smyczyńska, Joanna, et al.
Publicado: (2011) -
Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models
por: Smyczyńska, Urszula, et al.
Publicado: (2017) -
Significance of Direct Confirmation of Growth Hormone Insensitivity for the Diagnosis of Primary IGF-I Deficiency
por: Smyczyńska, Joanna, et al.
Publicado: (2020) -
Frequency of oligosymptomatic gastrointestinal tract diseases and its relation to insulin-like growth factor I in idiopathic (non-GH-deficient) short stature children
por: Stawerska, Renata, et al.
Publicado: (2020)